Cargando…

Pulmonary arterial hypertension incidence in Latvia in 2019

Detalles Bibliográficos
Autores principales:	Kaulins, Ricards, Rudzitis, Ainars, Lejnieks, Aivars, Sablinskis, Matiss, Skride, Andris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9709725/ https://www.ncbi.nlm.nih.gov/pubmed/36465603 http://dx.doi.org/10.1002/pul2.12161

Ejemplares similares

Baseline Clinical Characteristics and Incidence of Chronic Thromboembolic Pulmonary Hypertension Patients in Latvia, 2019–2020
por: Kauliņš, Ričards, et al.
Publicado: (2023)

Chronic Thromboembolic Pulmonary Hypertension Mimicking Acute Pulmonary Embolism: A Case Report
por: Kaulins, Ricards, et al.
Publicado: (2021)

Characteristics and survival data from Latvian pulmonary hypertension registry: comparison of prospective pulmonary hypertension registries in Europe
por: Skride, Andris, et al.
Publicado: (2018)

Pulmonary arterial hypertension in a patient treated with dasatinib: a case report
por: Skride, Andris, et al.
Publicado: (2017)

Pulmonary Endarterectomy in Latvia: A National Experience
por: Sablinskis, Matiss, et al.
Publicado: (2019)

Chronic Thromboembolic Pulmonary Hypertension and Antiphospholipid Syndrome with Immune Thrombocytopenia: A Case Report
por: Skride, Andris, et al.
Publicado: (2018)

Ambrisentan-induced severe asymptomatic thrombocytopenia
por: Kigitovica, Dana, et al.
Publicado: (2020)

Long-Term Response to Vasoactive Treatment in a Case of Kyphoscoliosis-Associated Pulmonary Hypertension
por: Tellermann, Jonas, et al.
Publicado: (2019)

Individually tailored home-based physiotherapy program makes sustainable improvement in exercise capacity and daily physical activity in patients with pulmonary arterial hypertension
por: Butāne, Līna, et al.
Publicado: (2022)

Numerical Response of Owls to the Dampening of Small Mammal Population Cycles in Latvia
por: Avotins, Andris, et al.
Publicado: (2023)

Ecogeographical variable dataset for species distribution modelling, describing forest landscape in Latvia, 2017
por: Avotins, Andris, et al.
Publicado: (2022)

Lead-Related Infective Endocarditis in Latvia: A Single Centre Experience
por: Nesterovics, Nikolajs, et al.
Publicado: (2019)

Venous Thromboembolism Recurrence in Latvian Population: Single University Hospital Data
por: Ģībietis, Valdis, et al.
Publicado: (2019)

Assessment of Iodine and Selenium Nutritional Status in Women of Reproductive Age in Latvia
por: Veisa, Vija, et al.
Publicado: (2021)

Inborn Errors of Immunity in Latvia: Analysis of Data from 1994 to 2020
por: Prokofjeva, Tatjana, et al.
Publicado: (2022)

Incidence of spontaneous subdural hematoma in incident cases of pulmonary arterial hypertension: a registry of cases occurring over a five-year period
por: Prada, Luis Felipe Lopes, et al.
Publicado: (2015)

Overdue to understand anticoagulation in pulmonary arterial hypertension
por: Parikh, Kishan S., et al.
Publicado: (2018)

Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
por: Yeo, Jina, et al.
Publicado: (2022)

Pulmonary artery sarcoma presenting as chronic thromboembolic pulmonary hypertension (CTEPH)
por: Ampatzidou, Fotini, et al.
Publicado: (2023)

Morphofunctional Characterization of Different Tissue Factors in Congenital Diaphragmatic Hernia Affected Tissue
por: Kaulins, Ricards, et al.
Publicado: (2021)

Comparison among Different Scoring Systems in Predicting Procedural Success and Long-Term Outcomes after Percutaneous Coronary Intervention in Patients with Chronic Total Coronary Artery Occlusions
por: Kalnins, Artis, et al.
Publicado: (2019)

Individually Tailored Remote Physiotherapy Program Improves Participation and Autonomy in Activities of Everyday Life along with Exercise Capacity, Self-Efficacy, and Low-Moderate Physical Activity in Patients with Pulmonary Arterial Hypertension: A Randomized Controlled Study
por: Butāne, Līna, et al.
Publicado: (2022)

Reply to “Bone morphogenetic protein's contribution to pulmonary artery hypertension”
por: King, Tyler, et al.
Publicado: (2016)

COVID-19 Vaccination Coverage and Factors Influencing Vaccine Hesitancy among Patients with Inborn Errors of Immunity in Latvia: A Mixed-Methods Study
por: Lucane, Zane, et al.
Publicado: (2023)

The Effect of General Bone Mineral Density on the Quantity and Quality of the Edentulous Mandible: A Cross-Sectional Clinical Study
por: Slaidina, Anda, et al.
Publicado: (2023)

Management of hospitalized patients with pulmonary arterial hypertension and COVID-19 infection
por: Sahay, Sandeep, et al.
Publicado: (2020)

Pulmonary arterial hypertension in systemic sclerosis—when criteria and pathobiology differ
por: Andréasson, Kristofer, et al.
Publicado: (2019)

Preoperative pulmonary artery hypertension as a risk factor: the tip of the iceberg
por: Engin, Mesut, et al.
Publicado: (2023)

Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines
por: Ahmed, Abdulla, et al.
Publicado: (2023)

Reversible pulmonary artery hypertension in association with interferon-beta therapy for multiple sclerosis
por: Baghizadeh, Somayyeh, et al.
Publicado: (2016)

15 years journey of idiopathic pulmonary arterial hypertension with BMPR2 mutation
por: Ahn, Kyung Jin, et al.
Publicado: (2019)

Latvia /
Publicado: (2001)

Novel therapy for idiopathic pulmonary arterial hypertension: Can hepatocyte growth factor be beneficial?
por: Guo, Ying-Hua, et al.
Publicado: (2012)

Epoprostenol discontinuation in patients with pulmonary arterial hypertension: a complex medical and social problem
por: Chebib, Nader, et al.
Publicado: (2017)

Prognostic role of traditional cardiovascular risk factors in patients with idiopathic pulmonary arterial hypertension
por: Kalemci, Serdar, et al.
Publicado: (2019)

Pulmonary paracoccidioidomycosis‐induced pulmonary hypertension
por: Batah, Sabrina Setembre, et al.
Publicado: (2020)

Interpretation of a new biomarker for the right ventricle introduced to evaluate the severity of pulmonary arterial hypertension
por: Kerkhof, Peter L.M., et al.
Publicado: (2019)

Ameliorated nailfold capillary morphology of patients with pulmonary arterial hypertension in systemic sclerosis, treated with riociguat
por: Sugimoto, Tomohiro, et al.
Publicado: (2023)

Understanding the perspective of patients with pulmonary arterial hypertension: looking beyond health-related quality of life
por: Aguirre-Camacho, Aldo
Publicado: (2021)

Pulmonary artery hypertension in mitral stenosis: Role of right ventricular stroke volume, atrio-ventricular compliance, and pulmonary venous compliance
por: Neema, Praveen Kumar, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3vacbe2odtnkgngia0ioth7l8p